“Open it the fuck back up!” the muscular Matt Honeycutt commands, mic gripped in his left fist, mustache prickling with indignation. He is balefully slash lovingly surveying the crowd and finding it a ...

MOTHERS of Special Heroes (MOSH) marked their fourth anniversary with a touching Christmas celebration held on December 11 at the Church of Christ in Bulawayo. The event brought together families, ...

Jacksonville's Museum of Science and History still needs to raise tens of millions of dollars for its new riverfront location. MOSH has proposed reducing on-site parking to cut construction costs by ...

With no negotiations, no oversight and no clarity about Iran’s stock of nuclear material, many in the region fear another war with Israel is inevitable. By Steven Erlanger Steven Erlanger has written ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...

Gilead Sciences, Inc. (NASDAQ:GILD) on Monday entered into settlement agreements to resolve the patent litigations with Lupin Ltd., Cipla Ltd. and Laurus Labs Ltd., generic manufacturers that filed ...

Exposition Park felt more like a festival than a single-band show on Friday, Oct. 4, as fans flooded in early for Turnstile’s sold-out Los Angeles stop. The air buzzed with anticipation and the smell ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...